• By ICR Secretariat
  • Posted Thursday, September 9, 2021

At FDA meeting, gene therapy experts wrestle with field's blindspots


A group of gene therapy experts called for better research tools and more careful monitoring of side effects to treatment, but stopped short in a high-profile meeting Thursday of advocating for major changes to how studies in the fast-growing field are conducted.